These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 4027482)
21. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog. Bass AS; Kohli JD; Lubbers N; Goldberg LI J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876 [TBL] [Abstract][Full Text] [Related]
22. Effects of dopexamine on hemodynamics and oxygen consumption after beta blockade in lambs. Taylor BJ; Rogers BW; Sziszak TL; Sziszak TJ Crit Care Med; 1993 May; 21(5):733-9. PubMed ID: 8386999 [TBL] [Abstract][Full Text] [Related]
23. Effects of the angiotensin AT1 receptor antagonist GRI38950 on haemodynamic function in dogs. Hunt AA; Hilditch A; Drew GM J Auton Pharmacol; 1997 Feb; 17(1):1-11. PubMed ID: 9201554 [TBL] [Abstract][Full Text] [Related]
24. Changes in regional blood flow distribution induced by infusions of dopexamine hydrochloride or dobutamine in anesthetized dogs. Biro GP; Douglas JR; Keon WJ; Taichman GC Am J Cardiol; 1988 Aug; 62(5):30C-36C. PubMed ID: 3407595 [TBL] [Abstract][Full Text] [Related]
25. Hemodynamic comparison of dopexamine and nitroprusside at high and low doses in patients with coronary artery disease and impaired left ventricular function. Ikram H; Foy SG; Low CJ; Redfern SA; Shirlaw TM; Bennett SI; Crozier IG J Cardiovasc Pharmacol; 1995 Nov; 26(5):777-83. PubMed ID: 8637193 [TBL] [Abstract][Full Text] [Related]
26. Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure. Tan LB; Littler WA; Murray RG Int J Cardiol; 1991 Feb; 30(2):203-8. PubMed ID: 2010243 [TBL] [Abstract][Full Text] [Related]
27. Comparison of acute haemodynamic effects of dopexamine hydrochloride, dobutamine and sodium nitroprusside in chronic heart failure. Baumann G; Gutting M; Pfafferott C; Ningel K; Klein G Eur Heart J; 1988 May; 9(5):503-12. PubMed ID: 3402466 [TBL] [Abstract][Full Text] [Related]
28. Evidence against a role for dopamine D1 receptors in the myocardium of the pig. Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206 [TBL] [Abstract][Full Text] [Related]
29. Effects of chronic intravenous infusions of dopexamine and isoprenaline to rats on D1-, beta 1- and beta 2-receptor-mediated responses. Martin SW; Broadley KJ Br J Pharmacol; 1994 Jun; 112(2):595-603. PubMed ID: 7915614 [TBL] [Abstract][Full Text] [Related]
30. Regional blood flow effects of dopexamine versus enalaprilat during propofol anaesthesia in rabbits with experimental chronic heart failure. Blake DW; Way D; Trigg L; McGrath BP Cardiovasc Res; 1994 May; 28(5):710-4. PubMed ID: 8025917 [TBL] [Abstract][Full Text] [Related]
31. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs. Sassen LM; Soei LK; Koning MM; Verdouw PD Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400 [TBL] [Abstract][Full Text] [Related]
32. An introduction to the pharmacologic properties of Dopacard (dopexamine hydrochloride). Smith GW; O'Connor SE Am J Cardiol; 1988 Aug; 62(5):9C-17C. PubMed ID: 2900602 [TBL] [Abstract][Full Text] [Related]
33. The haemodynamic and myocardial effects of dopexamine: a new beta 2-adrenoceptor and dopaminergic agonist. Jaski BE; Wijns W; Foulds R; Serruys PW Br J Clin Pharmacol; 1986 Apr; 21(4):393-400. PubMed ID: 2871852 [TBL] [Abstract][Full Text] [Related]
34. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure. Jamison M; Widerhorn J; Weber L; Campese V; Vasquez J; Hovanessian L; Rahimtoola SH; Elkayam U Am Heart J; 1989 Mar; 117(3):607-14. PubMed ID: 2537556 [TBL] [Abstract][Full Text] [Related]
35. Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine. Jaski BE; Peters C Am J Cardiol; 1988 Aug; 62(5):63C-67C. PubMed ID: 3407597 [TBL] [Abstract][Full Text] [Related]
36. Enhancing liver blood flow after cardiopulmonary bypass: the effects of dopamine and dopexamine. Sharpe DA; Mitchel IM; Kay EA; McGoldrick JP; Munsch CM; Kay PH Perfusion; 1999 Jan; 14(1):29-36. PubMed ID: 10074644 [TBL] [Abstract][Full Text] [Related]
37. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction. van Woerkens LJ; van der Giessen WJ; Verdouw PD Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521 [TBL] [Abstract][Full Text] [Related]
38. The selective effects of dopamine and dobutamine on liver circulation in the dog. Kinoshita G; Washizu M; Murata N; Kondo M; Matsukura Y; Washizu T; Motoyoshi S J Vet Med Sci; 1995 Apr; 57(2):293-7. PubMed ID: 7492649 [TBL] [Abstract][Full Text] [Related]
39. A novel orally active dopamine (DA) prodrug TA-870. IV. Renal vasodilatory and negative chronotropic effects in anesthetized dogs: influence of DA1 and DA2 dopamine receptor selective antagonists. Nishiyama S; Yoshikawa M; Yamaguchi I J Cardiovasc Pharmacol; 1991 Apr; 17(4):560-7. PubMed ID: 1711621 [TBL] [Abstract][Full Text] [Related]
40. Prolonged infusion of varied doses of dopexamine hydrochloride for low cardiac output after cardiac surgery. Santman FW J Cardiothorac Vasc Anesth; 1992 Oct; 6(5):568-72. PubMed ID: 1358247 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]